The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology.

[1]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[2]  B. Pitt.  Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). , 1996, The American journal of cardiology.

[3]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[4]  U. Elkayam,et al.  Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. , 1995, Journal of the American College of Cardiology.

[5]  H. Krum,et al.  Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. , 1995, Circulation.

[6]  A. Gentile,et al.  Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). , 1995, American heart journal.

[7]  R. Falk,et al.  Is aspirin safe for patients with heart failure? , 1995, British heart journal.

[8]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[9]  G. Schuler,et al.  Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. , 1995, Journal of the American College of Cardiology.

[10]  W. Remme,et al.  Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure. , 1994, Journal of cardiovascular pharmacology.

[11]  C. Brunelli,et al.  Efficacy of L-propionylcarnitine treatment in patients with left ventricular dysfunction. , 1994, European heart journal.

[12]  H. Doval,et al.  Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.

[13]  O. Alfieri,et al.  Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. , 1994, Journal of the American College of Cardiology.

[14]  K. Channer,et al.  Combination diuretic treatment in severe heart failure: a randomised controlled trial. , 1994, British heart journal.

[15]  K. Swedberg,et al.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.

[16]  M. Gheorghiade,et al.  WITHDRAWAL OF DIGOXIN FROM PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS , 2010 .

[17]  J. Brouwer,et al.  Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). , 1993, Journal of the American College of Cardiology.

[18]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[19]  B. Uretsky,et al.  Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. , 1993, Journal of the American College of Cardiology.

[20]  M. Borggrefe,et al.  Do patients with an implantable defibrillator live longer? , 1993, Journal of the American College of Cardiology.

[21]  A. Donker,et al.  Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. , 1993, The American journal of cardiology.

[22]  D. Cooper,et al.  Returning to work after heart transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[24]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[25]  F. Rengo,et al.  Controlled study on the therapeutic efficacy of propionyl-L-carnitine in patients with congestive heart failure. , 1992, Arzneimittel-Forschung.

[26]  G. Riegger,et al.  Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure. , 1992, The American journal of cardiology.

[27]  K. Swedberg,et al.  Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial). , 1992, The American journal of cardiology.

[28]  H. Crijns,et al.  Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. , 1992, JAMA.

[29]  S. Adamopoulos,et al.  Controlled Trial of Physical Training in Chronic Heart Failure: Exercise Performance, Hemodynamics, Ventilation, and Autonomic Function , 1992, Circulation.

[30]  R. Campbell,et al.  Guidelines for the use of implantable cardioverter defribrillators , 1992 .

[31]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.

[32]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[33]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[34]  J. Anderson,et al.  Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States. , 1991, American heart journal.

[35]  H. Herrmann,et al.  Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. , 1990, Circulation.

[36]  E. Fleck,et al.  Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases. , 1990, The American journal of cardiology.

[37]  S. Adamopoulos,et al.  Effects of physical training in chronic heart failure , 1990, The Lancet.

[38]  W. Stevenson,et al.  Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. , 1989, Circulation.

[39]  S. Rahimtoola,et al.  The hibernating myocardium. , 1989, American heart journal.

[40]  J Brandt,et al.  Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. , 1988, American heart journal.

[41]  S. Gottlieb,et al.  Prevention and reversal of nitrate tolerance in patients with congestive heart failure. , 1987, The New England journal of medicine.

[42]  C. Cipolla,et al.  Hemofiltration as short-term treatment for refractory congestive heart failure. , 1987, The American journal of medicine.

[43]  G. Flaker,et al.  Comparative survival following permanent ventricular and dual-chamber pacing for patients with chronic symptomatic sinus node dysfunction with and without congestive heart failure. , 1987, American heart journal.

[44]  B. Pitt,et al.  Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. , 1986, American heart journal.

[45]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[46]  G. Flaker,et al.  Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure. , 1986, Journal of the American College of Cardiology.

[47]  R. Gunnar,et al.  Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. , 1985, Circulation.

[48]  J. Anderson,et al.  A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. , 1985, The American journal of cardiology.

[49]  R. Luchi,et al.  Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure , 1984, Journal of the American Geriatrics Society.

[50]  K. Swedberg,et al.  Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. , 1980, British heart journal.

[51]  C. Edmonds,et al.  Total-body potassium in hypertension patients during prolonged diuretic therapy. , 1972, Lancet.